Formulation and Evaluation of Isorhamnetin SNEDDS for Neuroprotection in Alzheimer's Disease

Abstract

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. The disease is marked by the accumulation of amyloid‐beta plaques and tau tangles, which disrupt neuronal function and lead to cell death.

The paper